CSNpharm

CSNpharm logo

Csnpharm is committed to providing you with high quality products and outstanding services. We supply over 5000 bioactive compounds in stock, including inhibitors, agonists and natural products for laboratory and scientific use. Csnpharm has always been committed to develop quality products that are validated by NMR, UPLC, LC-MS, GC, Chiral HPLC and so on. We have a professional technical support team for customer service with years of experience in life science. Csnpharm is your reliable partner for scientific research.

Company Website

Product Listing

Tazarotene 10mg  | ≥97%

CSNpharm

Tazarotene selectively binds to retinoic acid receptors RAR-β and RAR-γ, it is the first receptor-selective aromatic retinoid that has effective treatment for psoriasis, hemorrhoids.

More Information Supplier Page

Tazarotene 100mg  | ≥97%

CSNpharm

Tazarotene selectively binds to retinoic acid receptors RAR-β and RAR-γ, it is the first receptor-selective aromatic retinoid that has effective treatment for psoriasis, hemorrhoids.

More Information Supplier Page

Tazarotene 25mg  | ≥97%

CSNpharm

Tazarotene selectively binds to retinoic acid receptors RAR-β and RAR-γ, it is the first receptor-selective aromatic retinoid that has effective treatment for psoriasis, hemorrhoids.

More Information Supplier Page

Tazarotene 50mg  | ≥97%

CSNpharm

Tazarotene selectively binds to retinoic acid receptors RAR-β and RAR-γ, it is the first receptor-selective aromatic retinoid that has effective treatment for psoriasis, hemorrhoids.

More Information Supplier Page

TBB 50mg  | ≥99%

CSNpharm

TBB is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).

More Information Supplier Page

TBB 10mg  | ≥99%

CSNpharm

TBB is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2)with IC50s of 0.9 and 1.6 μM for rat liver and human recombinant CK2 respectively).

More Information Supplier Page

TBHBA 5g  | ≥98%

CSNpharm

TBHBA can reacts with hydrogen peroxide and 4-aminophenazone to produce a quinone-imine dye with a greater molar absorptivity than that produced with phenol.

More Information Supplier Page

TBHBA 250mg  | ≥98%

CSNpharm

TBHBA can reacts with hydrogen peroxide and 4-aminophenazone to produce a quinone-imine dye with a greater molar absorptivity than that produced with phenol.

More Information Supplier Page

TC E3 5032 10mg  | ≥98%

CSNpharm

TC E3 5032 is a thalidomide derivate for conjugation reactions of PROTAC, which can hijack cereblon as the E3 ubiquitin ligase component.

More Information Supplier Page

TC E3 5032 250mg  | ≥98%

CSNpharm

TC E3 5032 is a thalidomide derivate for conjugation reactions of PROTAC, which can hijack cereblon as the E3 ubiquitin ligase component.

More Information Supplier Page

TC E3 5032 50mg  | ≥98%

CSNpharm

TC E3 5032 is a thalidomide derivate for conjugation reactions of PROTAC, which can hijack cereblon as the E3 ubiquitin ligase component.

More Information Supplier Page

TC E3 5032 100mg  | ≥98%

CSNpharm

TC E3 5032 is a thalidomide derivate for conjugation reactions of PROTAC, which can hijack cereblon as the E3 ubiquitin ligase component.

More Information Supplier Page

TC E3 5032 1g  | ≥98%

CSNpharm

TC E3 5032 is a thalidomide derivate for conjugation reactions of PROTAC, which can hijack cereblon as the E3 ubiquitin ligase component.

More Information Supplier Page

TCID 1mg  | ≥98%

CSNpharm

TCID is a DUB inhibitor for ubiquitin C-terminal hydrolase L3 with IC50 of 0.6 μM, 125-fold selective to L1.

More Information Supplier Page

TCID 5mg  | ≥98%

CSNpharm

TCID is a DUB inhibitor for ubiquitin C-terminal hydrolase L3 with IC50 of 0.6 μM, 125-fold selective to L1.

More Information Supplier Page

TDZD-8 10mg  | ≥99%

CSNpharm

TDZD-8, the derivative of thiadiazolidinone, is a selective inhibitor of GSK-3. It inhibits GSK-3β with IC50 of 2 μM.

More Information Supplier Page

TDZD-8 1mg  | ≥99%

CSNpharm

TDZD-8, the derivative of thiadiazolidinone, is a selective inhibitor of GSK-3. It inhibits GSK-3β with IC50 of 2 μM.

More Information Supplier Page

TDZD-8 5mg  | ≥99%

CSNpharm

TDZD-8, the derivative of thiadiazolidinone, is a selective inhibitor of GSK-3. It inhibits GSK-3β with IC50 of 2 μM.

More Information Supplier Page

TDZD-8 50mg  | ≥99%

CSNpharm

TDZD-8, the derivative of thiadiazolidinone, is a selective inhibitor of GSK-3. It inhibits GSK-3β with IC50 of 2 μM.

More Information Supplier Page

TDZD-8 100mg  | ≥99%

CSNpharm

TDZD-8, the derivative of thiadiazolidinone, is a selective inhibitor of GSK-3. It inhibits GSK-3β with IC50 of 2 μM.

More Information Supplier Page

Tebipenem Pivoxil 1mg  | ≥99%

CSNpharm

Tebipenem Pivoxil is a pivaloyloxymethyl ester prodrug of tebipenem with improved bioavailability, which works as a broad-spectrum antibiotic.

More Information Supplier Page

Tebipenem Pivoxil 5mg  | ≥99%

CSNpharm

Tebipenem Pivoxil is a pivaloyloxymethyl ester prodrug of tebipenem with improved bioavailability, which works as a broad-spectrum antibiotic.

More Information Supplier Page

Tebipenem Pivoxil 25mg  | ≥99%

CSNpharm

Tebipenem Pivoxil is a pivaloyloxymethyl ester prodrug of tebipenem with improved bioavailability, which works as a broad-spectrum antibiotic.

More Information Supplier Page